Salk Institute researchers have identified a key protein that may help users of GLP-1 drugs such as Ozempic and Wegovy ...

Salk scientists identify protein BCL6 as a key regulator of muscle maintenance in mice; BCL6-enhancing therapies may prevent ...

New research highlights the potential of the protein BCL6 in preserving muscle mass, especially when used with popular weight ...

Scientists unveil groundbreaking research on BCL6 protein that could help Ozempic users maintain muscle while losing weight. Here's what you need to know ...

New research highlights BCL6 protein’s role in preventing muscle loss during GLP-1 medication use, offering hope for ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal. But weight loss doesn't discriminate ...

If you're one of the 13% of American adults who has taken a GLP-1 drug for weight loss, you may know that while fat seemingly ...

Maintaining muscle mass is crucial for health, and researchers have identified the protein BCL6 as vital for this. Studies ...

About one in eight adults in the United States has tried or currently uses a GLP-1 medication, and a quarter of those users cite weight loss as their main goal.

A new study suggests protein could help you lose fat without sacrificing muscle mass, offering hope for those looking to ...

索尔克研究所的一项新研究表明，一种名为BCL6的蛋白质是保持健康肌肉质量的关键。实验表明，BCL6水平较低的小鼠肌肉质量和力量明显减少，但BCL6水平升高成功地逆转了这些损失。结果表明，将GLP-1药物与BCL6增强药物配对可能有助于抵消不必要的肌肉损失。类似的疗法也可以用于治疗其他容易肌肉损失的人群，比如老年人和患有败血症或癌症等全身性疾病的患者。